Top researchers in andrology: a bibliometric and demographic analysis of the last 7 years

The aim of this study is to perform a bibliometric and demographic analysis of the 10 most productive researchers over the past 7 years in relation to the selection of key topics in andrology. We conducted a bibliometric analysis in December 2023, using Scopus Researcher Discovery. Seven major andrological topics were identified: erectile dysfunction (T1), premature ejaculation (T2), male infertility (T3), Peyronie’s disease (T4), male hypogonadism (T5), priapism (T6), and low sexual desire (T7). A total of 10 researchers per topic were identified (51 unique authors). Most were urologists (65%) or endocrinologists (23%). Most authors belonged to centers in the USA (35.7%) and Italy (32.9%). The majority of authors were male (77.1%) and over 40 years old (83.3%of authors of known age). The mean (standard deviation (SD)) H-index of the 10 top researchers was 42.6 (24.6), ranging from 6 to 119. Male infertility was the topic with the most articles (1110) written by the top 10 researchers and the most cited (20,585). Erectile dysfunction was the second topic for articles (678) and third for citations after male hypogonadism (6046 vs. 11,384). The mean (SD) impact factor of the journals in which the andrological articles were published varied from 3.5 (0.53) for premature ejaculation to 5.33 (1.85) for hypogonadism.

Andrology; Bibliometric; Demographic; Researcher; Sexual medicine

[1] Rankin TL. Andrology as the medical speciality to focus medical training on men’s health? The Journal of Men’s Health & Gender. 2005; 2: 45–48.

[2] Lenzi A, Jannini EA. The andrologist from medicine of reproduction to sexual medicine: the Italian experience. International Journal of Andrology. 2005; 28: 9–13.

[3] Agarwal A, Saleh R, Boitrelle F, Cannarella R, Hamoda TAA, Durairajanayagam D, et al. The global andrology forum (GAF): a world-wide, innovative, online initiative to bridge the gaps in research and clinical practice of male infertility and sexual health. The World Journal of Men’s Health. 2022; 40: 537.

[4] Agarwal A, Durairajanayagam D, Tatagari S, Esteves S, Harlev A, Henkel R, et al. Bibliometrics: tracking research impact by selecting the appropriate metrics. Asian Journal of Andrology. 2016; 18: 296–309.

[5] Dilixiati D, Waili A, Tuerxunmaimaiti A, Tao L, Zebibula A, Rexiati M. Risk factors for erectile dysfunction in diabetes mellitus: a systematic review and meta-analysis. Frontiers in Endocrinology. 2024; 15: 1368079.

[6] Corona G, Rastrelli G, Vignozzi L, Maggi M. Androgens and male sexual function. Best practice & research. Clinical Endocrinology & Metabolism. 2022; 36: 101615.

[7] Grinspon RP, Bergadá I, Rey RA. Male hypogonadism and disorders of sex development. Frontiers in Endocrinology. 2020; 11: 211

[8] Elsevier. How can I best use the advanced search Scopus: access and use support center. 2024. Available at: https://www.elsevier.com/products/scopus/author-profiles#2-researcher-discovery (Accessed: 04 May 2024).

[9] Salonia A, Bettochi C, Capogrosso P, Carvalho J, Cilesiz NC, Cocci A, et al. EAU guidelines on sexual and reproductive health. 2023. Available at: https://uroweb.org/guidelines/sexual-and-reproductive-health (Accessed: 04 May 2024).

[10] Minhas S, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. European association of urology guidelines on male sexual and reproductive health: 2021 update on male infertility. European Urology. 2021; 80: 603–620.

[11] Bohrmann L, Daniel HD. Does the h-index for ranking of scientists really work? Scientometrics. 2005; 65: 391–392.

[12] Teixeira da Silva JA, Al-Khatib A. The ClarivateTM analytics acquisition of publons—an evolution or commodification of peer review? Research Ethics. 2019; 15: 438–444.

[13] Garrido-Abad P, Senra-Bravo I, Manfredi C, Fernández-Pascual E, Linares-Espinós E, Fernández-Arjona M,et al. Combination therapy with topical alprostadil and phosphodiesterase-5 inhibitors after failure of oral therapy in patients with erectile dysfunction: a prospective, two-arm, open-label, non-randomized study. International Journal of Impotence Research. 2022; 34: 164–171.

[14] Krausz C, Brannigan RE, Sigman M. Subspecialty training in andrology. Fertility and Sterility. 2015; 104: 12–15.

[15] Danis R, Sriprasert I, Petok W, Stone J, Paulson R, Samplaski M. Does male fertility-related quality of life differ when undergoing evaluation by reproductive urologist versus reproductive endocrinologist? Human Fertility. 2023; 26: 276–283.

[16] Isidori AM, Aversa A, Calogero A, Ferlin A, Francavilla S, Lanfranco F, et al. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian society of andrology and sexual medicine (SIAMS) and the Italian society of endocrinology (SIE). Journal of Endocrinological Investigation. 2022; 45: 2385–2403.

[17] Di Bello F, Creta M, Napolitano L, Califano G, Passaro F, Morra S, et al. Male sexual dysfunction and infertility in spinal cord injury patients: state-of-the-art and future perspectives. Journal of Personalized Medicine. 2022; 12: 873.

[18] Calogero AE, Cannarella R, Agarwal A, Hamoda TAA, Rambhatla A, Saleh R, et al. The renaissance of male infertility management in the golden age of andrology. The World Journal of Men’s Health. 2023; 41: 237–254.

[19] European Society for Sexual Medicine. Committees. 2024. Available at: https://www.essm.org/society/who-we-are/committees/#- (Accessed: 05 May 2024).

[20] European Association of Urology. Young Academic Urologist. 2024. Available at: https://uroweb.org/offices/young-academic-urologists (Accessed: 05 May 2024).

[21] European Association of Urology. Sexual and reproductive health, EAU—guidelines. 2024. Available at: https://uroweb.org/guidelines (Accessed: 03 May 2024).

[22] Wang M, Xue Y, Wei M, Jiang H, Zhang X. Representation of women as editors in andrology journals. Andrology. 2022; 10: 1067–1072.

[23] Nettey OS, Fuchs JS, Kielb SJ, Schaeffer EM. Gender representation in urologic subspecialties. Urology. 2018; 114: 66–70

[24] Web of Science Group. Journal impact factor. 2024. Available at: https://clarivate.com/webofsciencegroup/solutions/journal-citation-reports/ (Accessed: 25 April 2024).

[25] Verze P, Sokolakis I, Manfredi C, Collà Ruvolo C, Hatzichristodoulou G, Romero-Otero J. Penile prosthesis implant in the management of Peyronies’ disease. Minerva Urology and Nephrology. 2021; 73: 196–214.

[26] de Vries CEJ, Veerman-Verweij EM, van den Hoogen A, de Man-van Ginkel JM, Ockhuijsen HDL. The psychosocial impact of male infertility on men undergoing ICSI treatment: a qualitative study. Reproductive Health. 2024; 21: 26.

[27] Nguyen HMT, Gabrielson AT, Hellstrom WJG. Erectile dysfunction in young men—a review of the prevalence and risk factors. Sexual Medicine Reviews. 2017; 5: 508–520.

[28] Otero JR, Manfredi C, Wilson SK. The good, the bad, and the ugly about surgical approaches for inflatable penile prosthesis implantation. International Journal of Impotence Research. 2022; 34: 128–137.

[29] Spirito L, Manfredi C, La Rocca R, Napolitano L, Di Girolamo A, Capece M, et al. Daily low-dose tadalafil may reduce the penile curvature progression rate in patients with acute Peyronie’s disease: a retrospective comparative analysis. International Journal of Impotence Research. 2024; 36: 129–134.

[30] Biebel MG, Gross MS, Munarriz R. Review of ischemic and non-ischemic priapism. Current Urology Reports. 2022; 23: 143–153.